Market Place
Sourcing Support
SIGA Report Financial Results for 3 & 9 Months Ended Sept 30, 2024
07 Nov 2024 //
GLOBENEWSWIRE
SIGA to Host Q3 2024 Results Call on Nov 7, 2024
31 Oct 2024 //
GLOBENEWSWIRE
SIGA Licenses Novel Poxvirus Monoclonal Antibodies
22 Oct 2024 //
GLOBENEWSWIRE
Siga Technologies to supply mpox therapy in Morocco
08 Oct 2024 //
REUTERS
SIGA Announces Agreement to Supply TPOXX® in Morocco
08 Oct 2024 //
GLOBENEWSWIRE
SIGA Awarded $9M DOD Contract For TPOXX Procurement
21 Aug 2024 //
GLOBENEWSWIRE
Topline Results From PALM 007 Study Of Tecovirimat For Mpox Released
15 Aug 2024 //
GLOBENEWSWIRE
Siga`s Tpoxx Misses Efficacy Bar In Congo Mpox Study
15 Aug 2024 //
FIERCE PHARMA
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024
01 Aug 2024 //
GLOBENEWSWIRE
SIGA To Host Q2 2024 Results Call On August 1
25 Jul 2024 //
GLOBENEWSWIRE
Siga signs $113M US supply contract for mpox antiviral Tpoxx
19 Jul 2024 //
FIERCE PHARMA
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
19 Jul 2024 //
GLOBENEWSWIRE
SIGA Announces Agreement To Sell TPOXX® To ASEAN Member States
17 Jun 2024 //
GLOBENEWSWIRE
Calidi Partners With SIGA For Lung Cancer And Solid Tumor Virotherapy
10 Jun 2024 //
BUSINESSWIRE
SIGA Reports Financial Results for Three Months Ended March 31, 2024
07 May 2024 //
GLOBENEWSWIRE
SIGA Tech To Host Business Update Call On Q1 2024 Results May 7
01 May 2024 //
GLOBENEWSWIRE
SIGA Agreement with Meridian to Enhance Growth Opportunities of TPOXX®
01 Apr 2024 //
GLOBENEWSWIRE
SIGA Names Larry Miller General Counsel
25 Mar 2024 //
GLOBENEWSWIRE
SIGA Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
14 Mar 2024 //
YAHOO FINANCE
SIGA Declares Special Cash Dividend of $0.60 Per Share
12 Mar 2024 //
GLOBENEWSWIRE
SIGA Reports Financial Results for Three & Twelve Months Ended December 31, 2023
12 Mar 2024 //
GLOBENEWSWIRE
SIGA to Release of Fourth Quarter and Full Year 2023 Financial Results
05 Mar 2024 //
GLOBENEWSWIRE
SIGA Announces Appointment of Diem Nguyen as New Chief Executive Officer
22 Jan 2024 //
GLOBENEWSWIRE
SIGA Reports Financial Results for Three & Nine Months Ended September 30, 2023
07 Nov 2023 //
GLOBENEWSWIRE
SIGA to Host Call Following Release of Third Quarter 2023 Financial Results
26 Oct 2023 //
GLOBENEWSWIRE
SIGA Announces Creation of Joint Procurement Mechanism by European Commission
23 Oct 2023 //
GLOBENEWSWIRE
SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer
06 Sep 2023 //
GLOBENEWSWIRE
SIGA Technologies` Tecovirimat (tecovirimat) Receives Approval in Europe
23 Aug 2023 //
EMA
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023
08 Aug 2023 //
GLOBENEWSWIRE
Siga snares $138M US government contract to supply smallpox drug
31 Jul 2023 //
FIERCE PHARMA
SIGA Technologies to Release Second Quarter 2023 Financial Results
27 Jul 2023 //
GLOBENEWSWIRE
SIGA Announces U.S. Government Procurement Orders of $138M for Oral & IV TPOXX
27 Jul 2023 //
GLOBENEWSWIRE
U.S. orders antiviral drugs worth $138 million from SIGA Tech
27 Jul 2023 //
REUTERS
SIGA CEO Phil Gomez, PhD, to Present on Smallpox & Orthopox at NATO
27 Jun 2023 //
GLOBENEWSWIRE
SIGA Declares Special Cash Dividend of $0.45 Per Share
04 May 2023 //
GLOBENEWSWIRE
SIGA Reports Financial Results for Three Months Ended March 31, 2023
04 May 2023 //
GLOBENEWSWIRE
SIGA Technologies to Host Business Update Call on May 4th, 2023
27 Apr 2023 //
GLOBENEWSWIRE
SIGA Reports Financial Results for Three and Twelve Months Ended December 31
02 Mar 2023 //
GLOBENEWSWIRE
SIGA Technologies to Release Fourth Quarter and Full Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
SIGA Technologies Announces Planned Retirement of CEO Phil Gomez in 2023
17 Jan 2023 //
GLOBENEWSWIRE
SIGA Reports Financial Results for Three and Nine Months Ended Sep30, 2022
03 Nov 2022 //
GLOBENEWSWIRE
SIGA Technologies to Release Third Quarter 2022 Financial Results
27 Oct 2022 //
GLOBENEWSWIRE
SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ®
12 Oct 2022 //
GLOBENEWSWIRE
SIGA Technologies Announces New Contract Awarded by U.S.
29 Sep 2022 //
GLOBENEWSWIRE
Siga nabs $10.7M from the US government in deal for its monkeypox antiviral
29 Sep 2022 //
ENDPTS
SIGA Announces Approximately $16 M International for Oral TPOXX® (Tecovirimat)
26 Sep 2022 //
GLOBENEWSWIRE
FDA says overuse of Siga`s Tpoxx could render it ineffective
15 Sep 2022 //
FIERCEPHARMA
U.S. starts enrollment in trial testing Siga`s antiviral for monkeypox
09 Sep 2022 //
REUTERS
HHS earmarks $680M for smallpox drug, an Emergent buyout target
30 Aug 2022 //
FIERCEPHARMA
Oxford Uni scientists put Siga’s Tpoxx to the test for monkeypox
24 Aug 2022 //
PHARMAPHORUM
NIHR commissions clinical trial of monkeypox treatment
24 Aug 2022 //
CLINICALTRIALSARENA
British researchers behind RECOVERY return for monkeypox drug study
23 Aug 2022 //
ENDPTS
Monkeypox: History, traditional convention and even sitcom suggestions
16 Aug 2022 //
ENDPTS
Monkeypox Emergency Clearance Excludes Siga’s Tpoxx Medicine (2)
11 Aug 2022 //
RAPS
Feud between two biotechs left nearly 12M doses of monkeypox antiviral
10 Aug 2022 //
ENDPOINTS NEWS
U.S. to buy Siga`s IV drug worth $26 mln to fight monkeypox outbreak
10 Aug 2022 //
HEALTH ECONOMIC TIMES
SIGA Announces BARDA Exercise of Procurement Options at $26M for IV TPOXX
09 Aug 2022 //
GLOBENEWSWIRE
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2022
04 Aug 2022 //
GLOBENEWSWIRE
SIGA Technologies to Host Second Quarter 2022 Financial Results
28 Jul 2022 //
GLOBENEWSWIRE
Why Siga Technologies Stock Is Soaring Today
25 Jul 2022 //
FOOL
